Imatinib Mesylate and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia

This study has been terminated.

Study NCT00015847 Information provided by OHSU Knight Cancer Institute

First Received: May 6, 2001 Last Updated: June 16, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	May 2011
Primary Completion Date:	May 2011 (Final data collection date for primary outcome measure)